STAT+: Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share price

Novo Nordisk's shares rose after reporting improved earnings and guidance, driven by strong sales of its Wegovy pill. The company ticked up its adjusted sales and operating profit forecasts. This comes as a positive development for Novo Nordisk in the obesity drug market.